Assessment of Muscle Quantity, Quality and Function

Koo, Bo Kyung

doi:10.7570/jomes22025

Cited by 16 publications

(16 citation statements)

References 56 publications

(91 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Selvaraj et al [ 17 ] showed that axial muscle mass had a strong inverse relationship with NT-proBNP levels in patients with HF. However, their study had several limitations because they used axial muscle mass instead of appendicular muscle mass, even though appendicular muscle mass has more study data [ 17 , 18 ]. In addition, the study participants were mainly men and patients with HF [ 17 ].…”

Section: Discussionmentioning

confidence: 99%

“…By excluding patients with heart diseases at baseline and including both men and women in our study, we expanded the previous findings to the healthy adult population group. Furthermore, we used axial skeletal muscle mass, the sum of the muscle mass of the arms and legs, which is more widely used to assess muscle mass [ 18 ].…”

Section: Discussionmentioning

confidence: 99%

“…In addition, the authors hypothesized that BNP levels increase to protect against further muscle damage, as BNP was found to reduce skeletal muscle mitochondrial dysfunction and oxidative stress after ischemia-reperfusion [ 9 ]. Although the study was meaningful in that it proposed a potential mechanism of increased BNP in participants with decreased skeletal muscle mass, the study is limited as it used thigh muscle cross-sectional area to assess the muscle mass of participants, which is not a commonly used method, compared to BIA or DEXA, to assess skeletal muscle mass [ 9 , 18 ].…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Yoo

Kim

et al. 2023

Endocrinol Metab

View full text Add to dashboard Cite

Background: Sarcopenia, an age-related decline in muscle mass and function, is one of the most important health problems in elderly with a high rate of adverse outcomes. However, several studies have investigated the prevalence of sarcopenia in the world, the results have been inconsistent. The current systematic review and meta-analysis study was conducted to estimate the overall prevalence of sarcopenia in both genders in different regions of the world. Methods: Electronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched between January 2009 and December 2016. The population-based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were selected. According to these consensual definitions, sarcopenia was defined by presence of low muscle mass (adjusted appendicular muscle mass for height) and muscle strength (handgrip strength) or physical performance (the usual gait speed). The random effect model was used for estimation the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia and 95% confidence interval (CI) were calculated using the Binomial Exact Method. Heterogeneity was assessed by subgroup analysis. Results: Thirty-five articles met our inclusion criteria, with a total of 58404 individuals. The overall estimates of prevalence was 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women, respectively. The prevalence was higher among non-Asian than Asian individuals in both genders especially, when the Bio-electrical Impedance Analysis (BIA) was used to measure muscle mass (19% vs 10% in men; 20% vs 11% in women). Conclusion: Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass and different regions of the world for estimating parameters of sarcopenia, present systematic review revealed that a substantial proportion of the old people has sarcopenia, even in healthy populations. However, sarcopenia is as a consequence of the aging progress, early diagnosis can prevent some adverse outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Yoo

Kim

et al. 2023

Endocrinol Metab

View full text Add to dashboard Cite

show abstract

“…Besides the PhA, dynamometry also showed significant differences when analysing mortality; this was expected, as dynamometry indicates the patient's functionality and the quantity and quality of muscle mass (31) . Therefore, it should be considered in the nutritional assessment as it provides clinically relevant information and is an inexpensive method.…”

Section: Discussionmentioning

confidence: 63%

Total and segmental phase angle in a cohort of hospitalised patients with COVID-19: mortality prediction and changes throughout hospitalisation

Estrada-Moya,

González-Garay,

Flores-López

et al. 2023

Br J Nutr

View full text Add to dashboard Cite

Body composition and phase angle (PhA) have been used to predict mortality in multiple diseases. However, little has been studied regarding segmental measurements, which could potentially help assess subtle changes in specific tissue segments. This study aimed to identify the total PhA cut-off point associated with mortality risk and changes in body composition within a week of hospitalisation in non-critical hospitalised patients with COVID-19. A cohort study was conducted in which patients underwent a complete nutritional assessment upon admission and after seven days, if possible, and they were followed up until hospital discharge or death. A receiver operating characteristic curve was constructed to determine the PhA cut-off point, and the Kaplan–Meier estimator was used to determine survival analysis. Segmental and complete body compositions on admission and after 7 days were compared. We included 110 patients (60 men) with a mean age of 50.5 ± 15.0 years and a median body mass index of 28.5 (IQR, 25.6 to 33.5) kg/m2. The median length of hospital stay was 6 (IQR, 4 to 9) days, and the mortality rate was 13.6%. The PhA cut-off point obtained was 4°, with significant differences in the survival rate (p<0.001) and mortality (HR=5.81, 95% CI: 1.80 to 18.67, p= 0.003). Segmental and whole-body compositions were negatively affected within one week of hospitalisation, with changes in the approach by the graphical method in both sexes. Nutritional status deteriorates within a week of hospitalisation. PhA <4° is strongly associated with increased mortality in non-critical hospitalised patients with COVID-19.

show abstract

“…Previous indicators used to evaluate muscle reserve, such as anthropometrics, lab tests, subjective judgment, and body mass index (BMI), fail to reflect the patient’s body composition accurately ( 8 ). Clinicians may now directly measure muscle mass thanks to advances in imaging and software technologies ( 9 , 10 ). In particular, computed tomography (CT), has been recognized as the gold standard for identifying skeletal muscle because it can accurately distinguish skeletal muscle and fat mass using a single cross-sectional slice at multiple body levels ( 11 ).…”

Section: Introductionmentioning

confidence: 99%

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Zheng

Zhu²,

Yao³

et al. 2023

Front. Med.

View full text Add to dashboard Cite

ObjectiveSarcopenia is a syndrome of decreased muscle mass and deficits in muscle strength and physical function. We aimed to investigate the relationship between creatinine/cystatin C ratio (CCR) and sarcopenia and the prognostic value of CCR in hospitalized patients.Materials and methodsWe searched for relevant studies in PubMed, EMBASE, and the Cochrane Database up to August 25, 2022. Meta-analyses were performed to evaluate the relationship between CCR and skeletal muscle [computed tomography-assessed skeletal muscle (CTASM), muscle strength, and physical performance], prognosis and important clinical outcomes in hospitalized adults. The pooled correlation coefficient, the area under the receiver operating characteristic (ROC) curves, and hazard ratio (HR) together with their 95% confidence intervals (CIs) were calculated. We also conducted subgroup analyses to explore the sources of heterogeneity.ResultsA total of 38 studies with 20,362 patients were eligible. These studies were of moderate to high quality. Our results showed that CCR was significant correlations with all CTASM types (Fisher’s Z ranged from 0.35 to 0.5; P values ranged from < 0.01 to 0.01), handgrip strength (Fisher’s Z = 0.39; 95% CI, 0.32–0.45; P < 0.001) and gait speed (Fisher’s Z = 0.25; 95% CI, 0.21–0.30; P < 0.001). The ROC curves suggested that CCR had good diagnostic efficacy (0.689; 95% CI, 0.632–0.746; P < 0.01) for sarcopenia. CCR can reliably predict mortality in hospitalized patients, which was confirmed by regression analysis of CCR as both continuous (HR 0.78; 95% CI, 0.72–0.84; P < 0.01) and categorical variables (HR 2.05; 95% CI, 1.58–2.66; P < 0.0001). In addition, less evidence showed that higher CCR was independently associated with a shorter duration of mechanical ventilation, reduced length of stay in the intensive care unit and hospital, less nutritional risk, and decreased complications in hospitalized patients.ConclusionCCR could be a simple, economical, and effective screening tool for sarcopenia in hospitalized patients, and it is a helpful prognostic factor for mortality and other important clinical outcomes.Systematic review registrationhttps://inplasy.com/inplasy-2022-9-0097/, identifier INPLASY202290097.

show abstract

Assessment of Muscle Quantity, Quality and Function

Cited by 16 publications

References 56 publications

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Total and segmental phase angle in a cohort of hospitalised patients with COVID-19: mortality prediction and changes throughout hospitalisation

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Contact Info

Product

Resources

About